| Development of the Perceived Stress Questionnaire: a new tool for psychosomatic research S Levenstein, C Prantera, V Varvo, ML Scribano, E Berto, C Luzi, ... Journal of psychosomatic research 37 (1), 19-32, 1993 | 1310 | 1993 |
| Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG C Prantera, ML Scribano, G Falasco, A Andreoli, C Luzi Gut 51 (3), 405-409, 2002 | 746 | 2002 |
| Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission S Levenstein, C Prantera, V Varvo, ML Scribano, A Andreoli, C Luzi, ... Official journal of the American College of Gastroenterology| ACG 95 (5 …, 2000 | 620 | 2000 |
| Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn’s disease G Monteleone, MF Neurath, S Ardizzone, A Di Sabatino, MC Fantini, ... New England Journal of Medicine 372 (12), 1104-1113, 2015 | 475 | 2015 |
| An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin. C Prantera, F Zannoni, ML Scribano, E Berto, A Andreoli, A Kohn, C Luzi American Journal of Gastroenterology (Springer Nature) 91 (2), 1996 | 424 | 1996 |
| Psychological stress and disease activity in ulcerative colitis: a multidimensional cross-sectional study S Levenstein, C Prantera, V Varvo, ML Scribano, E Berto, A Andreoli, ... American Journal of Gastroenterology 89 (8), 1219-1225, 1994 | 255 | 1994 |
| Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn's disease C Prantera, H Lochs, M Grimaldi, S Danese, ML Scribano, P Gionchetti, ... Gastroenterology 142 (3), 473-481. e4, 2012 | 232 | 2012 |
| Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease C Brignola, M Cottone, A Pera, S Ardizzone, ML Scribano, R de Franchis, ... Gastroenterology 108 (2), 345-349, 1995 | 224 | 1995 |
| Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo‐controlled trial with rifaximin C Prantera, H Lochs, M Campieri, ML Scribano, GC Sturniolo, ... Alimentary pharmacology & therapeutics 23 (8), 1117-1125, 2006 | 211 | 2006 |
| Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non … BD Ye, M Pesegova, O Alexeeva, M Osipenko, A Lahat, A Dorofeyev, ... The Lancet 393 (10182), 1699-1707, 2019 | 194 | 2019 |
| Randomised controlled trial of mesalazine in IBS G Barbara, C Cremon, V Annese, G Basilisco, F Bazzoli, M Bellini, ... Gut 65 (1), 82-90, 2016 | 127 | 2016 |
| Curcumin and Fennel Essential Oil Improve Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome. P Portincasa, L Bonfrate, ML Scribano, A Kohn, N Caporaso, D Festi, ... Journal of Gastrointestinal & Liver Diseases 25 (2), 2016 | 114 | 2016 |
| Vedolizumab for inflammatory bowel disease: from randomized controlled trials to real-life evidence ML Scribano World journal of gastroenterology 24 (23), 2457, 2018 | 91 | 2018 |
| Use of antibiotics in the treatment of active Crohn's disease: experience with metronidazole and ciprofloxacin. C Prantera, E Berto, ML Scribano, G Falasco Italian journal of gastroenterology and hepatology 30 (6), 602-606, 1998 | 87 | 1998 |
| Antibiotics and probiotics in inflammatory bowel disease: why, when, and how C Prantera, ML Scribano Current opinion in gastroenterology 25 (4), 329-333, 2009 | 72 | 2009 |
| Probiotics and Crohn's disease C Prantera, ML Scribano Digestive and Liver Disease 34, S66-S67, 2002 | 66 | 2002 |
| Psychologic predictors of duodenal ulcer healing S Levenstein, C Prantera, ML Scribano, V Varvo, E Berto, S Spinella Journal of clinical gastroenterology 22 (2), 84-89, 1996 | 63 | 1996 |
| Early post-operative endoscopic recurrence in Crohn's disease patients: data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large … A Orlando, F Mocciaro, S Renna, D Scimeca, A Rispo, ML Scribano, ... Journal of Crohn's and Colitis 8 (10), 1217-1221, 2014 | 62 | 2014 |
| Patterns of biologic and psychologic risk factors in duodenal ulcer patients S Levenstein, C Prantera, V Varvo, ML Scribano, E Berto, S Spinella, ... Journal of clinical gastroenterology 21 (2), 110-117, 1995 | 62 | 1995 |
| Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case–Control IG-IBD Study L Biancone, A Armuzzi, ML Scribano, F Castiglione, R D’incà, A Orlando, ... Inflammatory Bowel Diseases 26 (3), 450-459, 2020 | 59 | 2020 |
